{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:14:25Z","timestamp":1779452065086,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013114","name":"Yunnan Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["202402AC100005"],"award-info":[{"award-number":["202402AC100005"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018637","name":"Yunnan Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019830","name":"Children's Hospital of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rpth.2026.103379","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:45:44Z","timestamp":1770047144000},"page":"103379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review"],"prefix":"10.1016","volume":"10","author":[{"given":"Shaoyu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-7695","authenticated-orcid":false,"given":"Zeping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103379_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.blre.2017.08.007","article-title":"Haemophilia B: where are we now and what does the future hold?","volume":"32","author":"Dolan","year":"2018","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.103379_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 6","key":"10.1016\/j.rpth.2026.103379_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib4","article-title":"Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B","volume":"2014","author":"Athale","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2026.103379_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2516.1996.tb00006.x","article-title":"Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large-scale North American survey","volume":"2","author":"Katz","year":"1996","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib6","first-page":"635","article-title":"Molecular genotyping of the Italian cohort of patients with hemophilia B","volume":"90","author":"Belvini","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.103379_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2516.2011.02700.x","article-title":"F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race\/ethnicity","volume":"18","author":"Miller","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103379_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/hae.12158","article-title":"Inhibitors in haemophilia B: the Italian experience","volume":"19","author":"Castaman","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/hae.12229","article-title":"Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database","volume":"20","author":"Puetz","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/JBM.S6885","article-title":"Treatment of hemophilia: a review of current advances and ongoing issues","volume":"1","author":"Coppola","year":"2010","journal-title":"J Blood Med"},{"key":"10.1016\/j.rpth.2026.103379_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103379_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/blood-2014-10-551952","article-title":"How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors","volume":"126","author":"Leissinger","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103379_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.12091","article-title":"Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization","volume":"160","author":"Collins","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103379_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/hae.12608","article-title":"Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres","volume":"21","author":"Nakar","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2010.08263.x","article-title":"Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches","volume":"150","author":"Coppola","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103379_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"International Immune Tolerance Study. The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103379_bib18","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2014-05-577643","article-title":"Toward optimal therapy for inhibitors in hemophilia","volume":"124","author":"Kempton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103379_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/hae.14577","article-title":"Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China","volume":"28","author":"Li","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2022.06.015","article-title":"Factor IX antibodies and tolerance in hemophilia B in the Nordic countries\u2014the impact of F9 variants and complications","volume":"217","author":"Kihlberg","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103379_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1612943","article-title":"North American Immune Tolerance Study Group. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors","volume":"87","author":"DiMichele","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103379_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/hae.14357","article-title":"The B-Natural study\u2014the outcome of immune tolerance induction therapy in patients with severe haemophilia B","volume":"27","author":"Astermark","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13052-015-0116-8","article-title":"Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review","volume":"41","author":"Bon","year":"2015","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.rpth.2026.103379_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2019.102370","article-title":"Allergy and inhibitors in hemophilia\u2014a rare complication with potential novel solutions","volume":"80","author":"Levy-Mendelovich","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.rpth.2026.103379_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00043426-199701000-00003","article-title":"Factor IX inhibitors and anaphylaxis in hemophilia B","volume":"19","author":"Warrier","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.rpth.2026.103379_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation","volume":"133","author":"Hay","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103379_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.103379_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/hae.14665","article-title":"Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China","volume":"29","author":"Dou","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103379_bib30","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/j.1538-7836.2011.04493.x","article-title":"The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience","volume":"9","author":"Kurth","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103379_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2516.2009.02039.x","article-title":"Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)","volume":"15","author":"Chitlur","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2516.1999.00195.x","article-title":"Tolerance induction using the Malm\u00f6 treatment model 1982-1995","volume":"5","author":"Freiburghaus","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2516.2008.01880.x","article-title":"The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy","volume":"15","author":"Dimichele","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/blood.V89.3.1115","article-title":"Nephrotic syndrome as a complication of immune tolerance in hemophilia B","volume":"89","author":"Ewenstein","year":"1997","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103379_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2007.01497.x","article-title":"International workshop on immune tolerance induction: consensus recommendations","volume":"13","author":"DiMichele","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103379_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0091-6749(98)70061-2","article-title":"IgE-mediated allergy and desensitization to factor IX in hemophilia B","volume":"102","author":"Dioun","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rpth.2026.103379_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2516.2001.0538c.x","article-title":"Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report","volume":"7","author":"Barnes","year":"2001","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103379_bib38","first-page":"S125","article-title":"Development of anaphylactic shock in haemophilia B patients with inhibitors","volume":"9","author":"Warrier","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.103379_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MPH.0b013e31815cf742","article-title":"Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis","volume":"30","author":"Alexander","year":"2008","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:04:01Z","timestamp":1779451441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2475037926000373"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103379","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103379"}}